148 related articles for article (PubMed ID: 37315433)
1. Non-coding RNAs in renal cell carcinoma: Implications for drug resistance.
Liu Y; Zhang H; Fang Y; Tang D; Luo Z
Biomed Pharmacother; 2023 Aug; 164():115001. PubMed ID: 37315433
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
Schanza LM; Seles M; Stotz M; Fosselteder J; Hutterer GC; Pichler M; Stiegelbauer V
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165391
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma.
Liu Y; Cheng G; Huang Z; Bao L; Liu J; Wang C; Xiong Z; Zhou L; Xu T; Liu D; Yang H; Chen K; Zhang X
Cell Death Dis; 2020 Jul; 11(7):515. PubMed ID: 32641718
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma.
Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X
Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
[TBL] [Abstract][Full Text] [Related]
6. Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms.
Lawrie CH; Armesto M; Fernandez-Mercado M; Arestín M; Manterola L; Goicoechea I; Larrea E; Caffarel MM; Araujo AM; Sole C; Sperga M; Alvarado-Cabrero I; Michal M; Hes O; López JI
J Mol Diagn; 2018 Jan; 20(1):34-45. PubMed ID: 29056573
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside compound K exerts antitumour effects in renal cell carcinoma via regulation of ROS and lncRNA THOR.
Chen S; Ye H; Gong F; Mao S; Li C; Xu B; Ren Y; Yu R
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649829
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of long non-coding RNA differentiation antagonizing non-protein coding RNA inhibits the proliferation, migration and invasion and promotes apoptosis of renal cell carcinoma.
Jin L; Fu H; Quan J; Pan X; He T; Hu J; Li Y; Li H; Yang Y; Ye J; Zhang F; Ni L; Yang S; Lai Y
Mol Med Rep; 2017 Oct; 16(4):4463-4468. PubMed ID: 28765964
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA DUXAP8 Enhances Renal Cell Carcinoma Progression via Downregulating miR-126.
Huang T; Wang X; Yang X; Ji J; Wang Q; Yue X; Dong Z
Med Sci Monit; 2018 Oct; 24():7340-7347. PubMed ID: 30317248
[TBL] [Abstract][Full Text] [Related]
10. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
Wu C; Zhang J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma.
Zhang M; Lu W; Huang Y; Shi J; Wu X; Zhang X; Jiang R; Cai Z; Wu S
J Mol Histol; 2016 Aug; 47(4):421-8. PubMed ID: 27323757
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA TUG1 promotes cell proliferation and migration of renal cell carcinoma via regulation of YAP.
Liu S; Yang Y; Wang W; Pan X
J Cell Biochem; 2018 Dec; 119(12):9694-9706. PubMed ID: 30132963
[TBL] [Abstract][Full Text] [Related]
13. Identification of long-non coding RNA UCA1 as an oncogene in renal cell carcinoma.
Li Y; Wang T; Li Y; Chen D; Yu Z; Jin L; Ni L; Yang S; Mao X; Gui Y; Lai Y
Mol Med Rep; 2016 Apr; 13(4):3326-34. PubMed ID: 26935146
[TBL] [Abstract][Full Text] [Related]
14. Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.
Seles M; Hutterer GC; Kiesslich T; Pummer K; Berindan-Neagoe I; Perakis S; Schwarzenbacher D; Stotz M; Gerger A; Pichler M
Int J Mol Sci; 2016 Apr; 17(4):573. PubMed ID: 27092491
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.
Hidaka H; Seki N; Yoshino H; Yamasaki T; Yamada Y; Nohata N; Fuse M; Nakagawa M; Enokida H
Oncotarget; 2012 Jan; 3(1):44-57. PubMed ID: 22294552
[TBL] [Abstract][Full Text] [Related]
16. Circular RNAs in renal cell carcinoma: implications for tumorigenesis, diagnosis, and therapy.
Wang Y; Zhang Y; Wang P; Fu X; Lin W
Mol Cancer; 2020 Oct; 19(1):149. PubMed ID: 33054773
[TBL] [Abstract][Full Text] [Related]
17. Renal cell carcinoma development and miRNAs: a possible link to the EGFR pathway.
Dias F; Teixeira AL; Santos JI; Gomes M; Nogueira A; Assis J; Medeiros R
Pharmacogenomics; 2013 Nov; 14(14):1793-803. PubMed ID: 24192126
[TBL] [Abstract][Full Text] [Related]
18. CRNDE mediates the viability and epithelial-mesenchymal transition of renal cell carcinoma via miR-136-5p.
Zhang Y; Lan X; Wang Y; Liu C; Cui T
J Recept Signal Transduct Res; 2021 Jun; 41(3):234-244. PubMed ID: 32808846
[TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA Emergence During Renal Cell Carcinoma Tumorigenesis.
Liu X; Hao Y; Yu W; Yang X; Luo X; Zhao J; Li J; Hu X; Li L
Cell Physiol Biochem; 2018; 47(2):735-746. PubMed ID: 29794462
[TBL] [Abstract][Full Text] [Related]
20. The emerging role of non-coding circulating RNA as a biomarker in renal cell carcinoma.
Ellinger J; Gevensleben H; Müller SC; Dietrich D
Expert Rev Mol Diagn; 2016 Oct; 16(10):1059-1065. PubMed ID: 27649770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
